SEGMENT REPORTING

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

SEGMENT REPORTING

18. SEGMENT REPORTING

Reportable segments are presented in a manner consistent with the internal reporting provided to the chief operating decision maker (CODM), the Chief Executive Officer of the Company. The CODM allocates resources to and assesses the performance of each segment using information about its revenue and operating income (loss). The Company’s operations involve products and services which are managed separately. Accordingly, it operates in two segments: 1) regenerative medicine products and 2) contract services.

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Three Months Ended March 31,
	2022			2021
Net revenues:
Reportable segments:
Regenerative medicine products	$	–		$	1,729
Contract services		741			2,980
Total net revenues	$	741		$	4,709
Net income/(loss):
Reportable segments:
Regenerative medicine products	$	(3,545	)	$	(17,702	)
Contract services		(226	)		292
Total net loss	$	(3,771	)	$	(17,410	)